EYALVI
DEAD
Serial Number
90433163
Owner
Tarsus Pharmaceuticals, Inc.Attorney
Catherine J. HollandFiling Date
Dec 30, 2020
EYALVI Trademark
Serial Number: 90433163
EYALVI is a trademark filed by
Tarsus Pharmaceuticals, Inc.
on December 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Catherine J. Holland KNOBBE MARTENS OLSON & BEAR, LLP
2040 MAIN STREET
14TH FLOOR
IRVINE
CA 92614
Trademark Details
Filing Date
December 30, 2020
Registration Date
Not Registered
Published for Opposition
August 3, 2021
Filing History
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 30, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2023 EXRA
SOU EXTENSION 3 GRANTED
Mar 14, 2023 EX3G
SOU EXTENSION 3 FILED
Mar 14, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2022 EXRA
SOU EXTENSION 2 GRANTED
Sep 8, 2022 EX2G
SOU EXTENSION 2 FILED
Sep 8, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 26, 2022 EXRA
SOU EXTENSION 1 GRANTED
Mar 24, 2022 EX1G
SOU EXTENSION 1 FILED
Mar 24, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 24, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 16, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2021 CNSA
ASSIGNED TO EXAMINER
Jun 29, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2021 NWOS
NEW APPLICATION ENTERED
Jan 2, 2021 NWAP
